PUBLISHER: BIS Research | PRODUCT CODE: 1546999
PUBLISHER: BIS Research | PRODUCT CODE: 1546999
Asia-Pacific Continuous Bioprocessing Market: Focus on Application, End User, Product, and Country - Analysis and Forecast, 2023-2033
Introduction to Asia-Pacific (APAC) Continuous Bioprocessing Market
The Asia-Pacific continuous bioprocessing market was valued at $51.0 million in 2023 and is expected to reach $388.5 million by 2033, growing at a CAGR of 22.50% between 2023 and 2033. Increased demand to improve biopharmaceutical production through increased yield, flexibility, productivity, and product consistency at the same time as lower manufacturing costs is driving the APAC market for continuous bioprocessing. In order to produce consistent results, bioprocessing has been moving toward continuous mode in recent years. The goal of ongoing efforts is to integrate downstream bioprocessing into a continuous operation, thereby increasing the efficiency and capabilities of the industry, even though continuous upstream bioprocessing has been established and widely adopted.
Market Introduction
| KEY MARKET STATISTICS | |
|---|---|
| Forecast Period | 2023 - 2033 |
| 2023 Evaluation | $51.0 Million |
| 2033 Forecast | $388.5 Million |
| CAGR | 22.5% |
The Asia-Pacific continuous bioprocessing market is expanding quickly as the area assumes a pivotal role in the worldwide biopharmaceutical sector. As the emphasis on improving productivity, adaptability, and product quality grows, continuous bioprocessing is becoming recognized as a game-changing strategy for biomanufacturing in the Asia-Pacific region. Many benefits, such as increased yields, lower manufacturing costs, and the capacity to produce reliable, high-quality products, make this strategy a desirable one for biopharmaceutical companies operating in the area.
The region's strong biopharmaceutical manufacturing infrastructure and the rising demand for novel therapies have led to the widespread adoption of continuous upstream bioprocessing in APAC. The emphasis now is on integrating continuous downstream bioprocessing, optimizing overall process efficiency, and further streamlining operations. With seamless production flows from beginning to end, decreased downtime, and improved scalability of biopharmaceutical production, this integration is predicted to be a game-changer.
The continuous development of bioprocessing technologies is being fueled by the region's substantial investment in research and development as well as encouraging government initiatives. Continuous bioprocessing adoption is expected to pick up speed as the APAC biopharmaceutical market grows, establishing the region as a pioneer in cutting-edge biomanufacturing techniques.
Market Segmentation
Segmentation 1: by Product
- Chromatography Systems and Consumables
- Filtration Systems and Devices
- Bioreactors
- Cell Culture Media, Cell Lines, Buffers, and Reagents
- Other Products
Segmentation 2: by Application
- Monoclonal Antibodies
- Vaccines
- Cell and Gene Therapy
- Other Applications
Segmentation 3: by End User
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Research Organizations
Segmentation 4: by Country
- Japan
- India
- China
- South Korea
- Australia
- Rest-of-Asia-Pacific
How can this report add value to an organization?
Product/Innovation Strategy: The Asia-Pacific continuous bioprocessing market has been segmented based on application, end user, and product. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.
Competitive Strategy: In the continuous bioprocessing market, competitive strategy centers around innovation, collaboration, customization, and sustainability. Companies in the market strive to innovate by developing more efficient, scalable, and flexible bioprocessing technologies that reduce production times and costs while maintaining high product quality. Collaboration between equipment manufacturers, biopharmaceutical companies, and research institutions is crucial for sharing knowledge, optimizing processes, and accelerating the adoption of continuous bioprocessing.
Table of Contents
Executive Summary
1 Markets
- 1.1 Trends: Current and Future Impact Assessment
- 1.1.1 Continuous Bioprocessing Market Trend Analysis
- 1.1.2 Digitization of Continuous Bioprocessing by the Biopharmaceutical Industry
- 1.1.3 Increasing Use of Single-Use or Disposable Bioprocessing Equipment
- 1.2 Supply Chain Overview
- 1.2.1 Value Chain Analysis
- 1.3 Research and Development Review
- 1.3.1 Patent Filing Trend (by Country, by Year)
- 1.4 Regulatory Landscape
- 1.5 Impact Analysis for Key Events: COVID-19
- 1.6 Market Dynamics Overview
- 1.6.1 Market Drivers
- 1.6.1.1 Growing Demand for Continuous Bioprocessing due to the Flourishing Biopharmaceutical Sector
- 1.6.1.2 Cost Reduction with Continuous Bioprocessing as Compared to Batch and Fed-Batch Bioprocessing
- 1.6.1.3 Increasing Adoption of New Technologies like Single-Use Bioprocessing Technology
- 1.6.2 Market Restraints
- 1.6.2.1 Technological Complexities and Operational Challenges
- 1.6.2.2 High Initial Cost Associated with Continuous Bioprocessing
- 1.6.3 Market Opportunities
- 1.6.3.1 Numerous Proposed Technologies in Continuous Bioprocessing
- 1.6.3.2 Moving Closer to End-to-End Continuous Bioprocessing
- 1.6.1 Market Drivers
2 Region
- 2.1 Regional Summary
- 2.2 Asia-Pacific
- 2.2.1 Regional Overview
- 2.2.2 Driving Factors for Market Growth
- 2.2.3 Factors Challenging the Market
- 2.2.4 Application
- 2.2.5 Product
- 2.2.6 China
- 2.2.7 Application
- 2.2.8 Product
- 2.2.9 India
- 2.2.10 Application
- 2.2.11 Product
- 2.2.12 Australia
- 2.2.13 Application
- 2.2.14 Product
- 2.2.15 Japan
- 2.2.16 Application
- 2.2.17 Product
- 2.2.18 South Korea
- 2.2.19 Application
- 2.2.20 Product
- 2.2.21 Rest-of-Asia-Pacific
- 2.2.22 Application
- 2.2.23 Product
3 Markets - Competitive Benchmarking & Company Profiles
- 3.1 Next Frontiers
- 3.2 Geographic Assessment
- 3.2.1 OmniBRx Biotechnologies Pvt Ltd.
- 3.2.1.1 Overview
- 3.2.1.2 Top Products/Product Portfolio
- 3.2.1.3 Top Competitors
- 3.2.1.4 Target Customers
- 3.2.1.5 Key Personnel
- 3.2.1.6 Analyst View
- 3.2.1 OmniBRx Biotechnologies Pvt Ltd.
4 Research Methodology
- 4.1 Data Sources
- 4.1.1 Primary Data Sources
- 4.1.2 Secondary Data Sources
- 4.1.3 Data Triangulation
- 4.2 Market Estimation and Forecast
List of Figures
- Figure 1: Asia-Pacific Continuous Bioprocessing Market, $Million, 2023, 2026, and 2033
- Figure 2: Asia-Pacific Continuous Bioprocessing Market (by Application), $Million, 2022, 2026, and 2033
- Figure 3: Asia-Pacific Continuous Bioprocessing Market (by Product), $Million, 2022, 2026, and 2033
- Figure 4: Asia-Pacific Continuous Bioprocessing Market (by End User), $Million, 2022, 2026, and 2033
- Figure 5: Evolution of Single-Use Facilities, 2019-2022
- Figure 6: Supply Chain and Identifying Risks within the Supply Chain
- Figure 7: Continuous Bioprocessing Market (by Country), January 2020-December 2023
- Figure 8: Continuous Bioprocessing Market (by Year), January 2020-December 2023
- Figure 9: Long-Term Effect of COVID-19 on Bioprocessing, Biopharma Vs Suppliers
- Figure 10: Impact of COVID-19 on the Continuous Bioprocessing Market, Pre, During, and Post-COVID-19 Scenario
- Figure 11: Impact Analysis of Market Navigating Factors, 2023-2033
- Figure 12: Growth of Biopharmaceutical Research and Development, 2012-2022, $ Million
- Figure 13: Comparison of Processes and Facilities for Different Batch Types
- Figure 14: Cost Comparison: Continuous vs. Batch and Fed-Batch Bioprocessing, $ Million
- Figure 15: Respondents Using Single-Use Bioprocessing Technology, All Scales (R&D to Commercial), 2018-2022, %
- Figure 16: Novel Bioprocessing Systems/Innovations Evaluated in 12 Months, 2021
- Figure 17: Factors Contributing to High Initial Costs in Continuous Bioprocessing Facilities
- Figure 18: Proposed Technologies in Continuous Biopharmaceutical Manufacturing
- Figure 19: Developments in Continuous Bioprocessing Generating Need for End-to-End Continuous Bioprocessing Facilities
- Figure 20: China Continuous Bioprocessing Market, $Million, 2022-2033
- Figure 21: India Continuous Bioprocessing Market, $Million, 2022-2033
- Figure 22: Australia Continuous Bioprocessing Market, $Million, 2022-2033
- Figure 23: Japan Continuous Bioprocessing Market, $Million, 2022-2033
- Figure 24: South Korea Continuous Bioprocessing Market, $Million, 2022-2033
- Figure 25: Rest-of-Asia-Pacific Continuous Bioprocessing Market, $Million, 2022-2033
- Figure 26: Strategic Initiatives, 2020-2023
- Figure 27: Share of Strategic Initiatives, 2020-2023
- Figure 28: Data Triangulation
- Figure 29: Top-Down and Bottom-Up Approach
- Figure 30: Assumptions and Limitations
List of Tables
- Table 1: Market Snapshot
- Table 2: Continuous Bioprocessing Market, Opportunities
- Table 3: Product Portfolio Company Positioning
- Table 4: Example of Digitization of Continuous Bioprocessing
- Table 5: Survey on Industry Perceptions of Continuous Bioprocessing Vs Batch-Fed Processing (N=140+ Biopharmaceutical Companies)
- Table 6: Continuous Bioprocessing Market (by Region), $Million, 2022-2033
- Table 7: Asia-Pacific Continuous Bioprocessing Market (by Application), $Million, 2022-2033
- Table 8: Asia-Pacific Continuous Bioprocessing Market (by End User), $Million, 2022-2033
- Table 9: Asia-Pacific Continuous Bioprocessing Market (by Product), $Million, 2022-2033
- Table 10: China Continuous Bioprocessing Market (by Application), $Million, 2022-2033
- Table 11: China Continuous Bioprocessing Market (by End User), $Million, 2022-2033
- Table 12: China Continuous Bioprocessing Market (by Product), $Million, 2022-2033
- Table 13: India Continuous Bioprocessing Market (by Application), $Million, 2022-2033
- Table 14: India Continuous Bioprocessing Market (by End User), $Million, 2022-2033
- Table 15: India Continuous Bioprocessing Market (by Product), $Million, 2022-2033
- Table 16: Australia Continuous Bioprocessing Market (by Application), $Million, 2022-2033
- Table 17: Australia Continuous Bioprocessing Market (by End User), $Million, 2022-2033
- Table 18: Australia Continuous Bioprocessing Market (by Product), $Million, 2022-2033
- Table 19: Japan Continuous Bioprocessing Market (by Application), $Million, 2022-2033
- Table 20: Japan Continuous Bioprocessing Market (by End User), $Million, 2022-2033
- Table 21: Japan Continuous Bioprocessing Market (by Product), $Million, 2022-2033
- Table 22: South Korea Continuous Bioprocessing Market (by Application), $Million, 2022-2033
- Table 23: South Korea Continuous Bioprocessing Market (by End User), $Million, 2022-2033
- Table 24: South Korea Continuous Bioprocessing Market (by Product), $Million, 2022-2033
- Table 25: Rest-of-Asia-Pacific Continuous Bioprocessing Market (by Application), $Million, 2022-2033
- Table 26: Rest-of-Asia-Pacific Continuous Bioprocessing Market (by End User), $Million, 2022-2033
- Table 27: Rest-of-Asia-Pacific Continuous Bioprocessing Market (by Product), $Million, 2022-2033
